Epithelial-mesenchymal cell transformation in the embryonic heart can be mediated, in part, by transforming growth factor β

Jay D. Potts, Raymond B Runyan

Research output: Contribution to journalArticle

214 Citations (Scopus)

Abstract

Progenitor cells of the valves and membranous septa of the vertebrate heart are formed by transformation of a specific population of endothelial cells into mesenchyme. Previous studies have shown that this epithelial-mesenchymal cell transformation is mediated by a signal produced by the myocardium of the atrioventricular (AV) canal and transferred across the extracellular matrix. Data are presented here that transforming growth factor β (TGFβ1 or TGFβ2), in combination with an explant of ventricular myocardium, will produce an epithelial-mesenchymal transformation by cultured AV canal endothelial cells in vitro. Alone, neither component is capable of producing this effect. The factor provided by the ventricular explant cannot be substituted by either epidermal growth factor or basic fibroblast growth factor. Further experiments show that an antibody that blocks TGFβ activity is effective in preventing the epithelial-mesenchymal cell transformation normally produced by AV canal myocardium. Control antibodies are without effect. By immunological criteria, a member of the TGFβ family of molecules can be demonstrated in the chicken embryo and heart at the time overt valvular formation begins. Together, these data show that TGFβ1 can produce mesenchymal cell formation in vitro and provide evidence that a member of the TGFβ family is present and plays a role in the process of epithelial-mesenchymal cell transformation in the embryonic heart.

Original languageEnglish (US)
Pages (from-to)392-401
Number of pages10
JournalDevelopmental Biology
Volume134
Issue number2
DOIs
StatePublished - 1989
Externally publishedYes

Fingerprint

Epithelial-Mesenchymal Transition
Transforming Growth Factors
Epithelial Cells
Myocardium
Heart Septum
Endothelial Cells
Antibodies
Fibroblast Growth Factor 2
Mesoderm
Epidermal Growth Factor
Extracellular Matrix
Vertebrates
Chickens
Stem Cells
Embryonic Structures
Population
In Vitro Techniques

ASJC Scopus subject areas

  • Developmental Biology

Cite this

Epithelial-mesenchymal cell transformation in the embryonic heart can be mediated, in part, by transforming growth factor β. / Potts, Jay D.; Runyan, Raymond B.

In: Developmental Biology, Vol. 134, No. 2, 1989, p. 392-401.

Research output: Contribution to journalArticle

@article{cdf11399556e45d5a38d28c8d53d6f94,
title = "Epithelial-mesenchymal cell transformation in the embryonic heart can be mediated, in part, by transforming growth factor β",
abstract = "Progenitor cells of the valves and membranous septa of the vertebrate heart are formed by transformation of a specific population of endothelial cells into mesenchyme. Previous studies have shown that this epithelial-mesenchymal cell transformation is mediated by a signal produced by the myocardium of the atrioventricular (AV) canal and transferred across the extracellular matrix. Data are presented here that transforming growth factor β (TGFβ1 or TGFβ2), in combination with an explant of ventricular myocardium, will produce an epithelial-mesenchymal transformation by cultured AV canal endothelial cells in vitro. Alone, neither component is capable of producing this effect. The factor provided by the ventricular explant cannot be substituted by either epidermal growth factor or basic fibroblast growth factor. Further experiments show that an antibody that blocks TGFβ activity is effective in preventing the epithelial-mesenchymal cell transformation normally produced by AV canal myocardium. Control antibodies are without effect. By immunological criteria, a member of the TGFβ family of molecules can be demonstrated in the chicken embryo and heart at the time overt valvular formation begins. Together, these data show that TGFβ1 can produce mesenchymal cell formation in vitro and provide evidence that a member of the TGFβ family is present and plays a role in the process of epithelial-mesenchymal cell transformation in the embryonic heart.",
author = "Potts, {Jay D.} and Runyan, {Raymond B}",
year = "1989",
doi = "10.1016/0012-1606(89)90111-5",
language = "English (US)",
volume = "134",
pages = "392--401",
journal = "Developmental Biology",
issn = "0012-1606",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Epithelial-mesenchymal cell transformation in the embryonic heart can be mediated, in part, by transforming growth factor β

AU - Potts, Jay D.

AU - Runyan, Raymond B

PY - 1989

Y1 - 1989

N2 - Progenitor cells of the valves and membranous septa of the vertebrate heart are formed by transformation of a specific population of endothelial cells into mesenchyme. Previous studies have shown that this epithelial-mesenchymal cell transformation is mediated by a signal produced by the myocardium of the atrioventricular (AV) canal and transferred across the extracellular matrix. Data are presented here that transforming growth factor β (TGFβ1 or TGFβ2), in combination with an explant of ventricular myocardium, will produce an epithelial-mesenchymal transformation by cultured AV canal endothelial cells in vitro. Alone, neither component is capable of producing this effect. The factor provided by the ventricular explant cannot be substituted by either epidermal growth factor or basic fibroblast growth factor. Further experiments show that an antibody that blocks TGFβ activity is effective in preventing the epithelial-mesenchymal cell transformation normally produced by AV canal myocardium. Control antibodies are without effect. By immunological criteria, a member of the TGFβ family of molecules can be demonstrated in the chicken embryo and heart at the time overt valvular formation begins. Together, these data show that TGFβ1 can produce mesenchymal cell formation in vitro and provide evidence that a member of the TGFβ family is present and plays a role in the process of epithelial-mesenchymal cell transformation in the embryonic heart.

AB - Progenitor cells of the valves and membranous septa of the vertebrate heart are formed by transformation of a specific population of endothelial cells into mesenchyme. Previous studies have shown that this epithelial-mesenchymal cell transformation is mediated by a signal produced by the myocardium of the atrioventricular (AV) canal and transferred across the extracellular matrix. Data are presented here that transforming growth factor β (TGFβ1 or TGFβ2), in combination with an explant of ventricular myocardium, will produce an epithelial-mesenchymal transformation by cultured AV canal endothelial cells in vitro. Alone, neither component is capable of producing this effect. The factor provided by the ventricular explant cannot be substituted by either epidermal growth factor or basic fibroblast growth factor. Further experiments show that an antibody that blocks TGFβ activity is effective in preventing the epithelial-mesenchymal cell transformation normally produced by AV canal myocardium. Control antibodies are without effect. By immunological criteria, a member of the TGFβ family of molecules can be demonstrated in the chicken embryo and heart at the time overt valvular formation begins. Together, these data show that TGFβ1 can produce mesenchymal cell formation in vitro and provide evidence that a member of the TGFβ family is present and plays a role in the process of epithelial-mesenchymal cell transformation in the embryonic heart.

UR - http://www.scopus.com/inward/record.url?scp=0024413336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024413336&partnerID=8YFLogxK

U2 - 10.1016/0012-1606(89)90111-5

DO - 10.1016/0012-1606(89)90111-5

M3 - Article

C2 - 2744239

AN - SCOPUS:0024413336

VL - 134

SP - 392

EP - 401

JO - Developmental Biology

JF - Developmental Biology

SN - 0012-1606

IS - 2

ER -